Gorlin Syndrome Challenge Grant
Gorlin Syndrome Challenge Grant supports researchers studying pediatric basal cell carcinoma in Gorlin syndrome to improve diagnosis, treatment, and quality of life for affected children and families.
Browse similar grants
Funder: Pediatric Dermatology Research Alliance
Due Dates: December 3, 2026, 11:59 PM PT (Application) | March 15, 2027 (Awards made by) | April 1, 2027 (Earliest start)
Funding Amounts: Up to $25,000 in direct costs for one year; one non-renewable award
Summary: Supports research on pediatric basal cell carcinoma in Gorlin syndrome to improve diagnosis, treatment, and quality of life.
Key Information: Applicants must hold an MD, PhD, or equivalent and be eligible to apply through their host institution.
Description
The Pediatric Dermatology Research Alliance (PeDRA) and Gorlin Syndrome Alliance (GSA) jointly fund high-impact research addressing pediatric basal cell carcinoma in Gorlin syndrome. The program aims to improve diagnosis, treatment, and quality of life for affected children and families, including the burdens of recurrent tumors, lifelong surveillance, scarring, procedural fatigue, and psychosocial anxiety.
Supported work may be basic, translational, clinical, epidemiologic, or patient-oriented. Topics include early-onset tumor biology, disease modifiers, recurrence, prevention and photoprotection, pediatric surveillance and biopsy standards, more tolerable treatments, and patient-centered outcomes. Clinical research is strongly encouraged, particularly studies improving care pathways, identifying unmet management needs, assessing multidisciplinary care models, or generating foundational data for prospective clinical trials.
